- Home
- CZFS vs PRQR Comparison
CZFS vs PRQR Comparison
Compare CZFS & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CZFS | PRQR |
|---|---|---|
| Founded | 1984 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.7M | 244.1M |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CZFS | PRQR |
|---|---|---|
| Price | $83.00 | $1.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.25 |
| AVG Volume (30 Days) | 26.1K | ★ 806.1K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.10% | N/A |
| EPS Growth | ★ 30.26 | N/A |
| EPS | ★ 4.28 | N/A |
| Revenue | ★ $9,881,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.64 | $13.92 |
| P/E Ratio | $19.23 | ★ N/A |
| Revenue Growth | ★ 2.82 | N/A |
| 52 Week Low | $52.35 | $1.33 |
| 52 Week High | $83.37 | $3.10 |
Technical Indicators
Market Signals| Indicator | CZFS | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 65.62 | 56.02 |
| Support Level | $55.53 | $1.37 |
| Resistance Level | $83.37 | $1.99 |
| Average True Range (ATR) | 3.12 | 0.10 |
| MACD | 0.32 | 0.01 |
| Stochastic Oscillator | 90.93 | 67.65 |
Price Performance
Historical ComparisonAbout CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.